April 09, 2026 05:15 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jaishankar’s high-stakes diplomatic tour: EAM to visit UAE this week, first visit amid Middle East conflict | Passport row: Barricades outside Pawan Khera’s Hyderabad house after Himanta Biswa Sarma's warning | ‘Allow excluded voters to vote’: Mamata slams voter list freeze amid SIR row, to move Supreme Court | US, Iran agree to 2-week ceasefire deal, reopening Strait of Hormuz | ‘Prudent to wait and watch’: RBI keeps repo rate unchanged at 5.25% amid global volatility | 91 lakh voters dropped from rolls in Bengal SIR; Muslim-majority Murshidabad tops deletion list | Air India CEO Campbell Wilson quits amid losses, regulatory heat after deadly Ahmedabad crash: Report | Could be taken out in one night: Donald Trump’s chilling warning to Iran as deadline approaches | IRGC Intelligence Chief Majid Khademi killed in Israeli-US strike | Setback for Arunachal CM Pema Khandu as SC orders CBI probe into public works contracts

Genpact appoints Hanspeter Spek as Director

| | Apr 04, 2014, at 12:08 am
New York, Apr 3 (IBNS): Business process management company Genpact Limited on Thursday announced Hanspeter Spek as a member of its Board of Directors.
“We are honored to have Hanspeter join the Genpact Board. With his extensive global experience, he will bring significant value to Genpact and its Board,” said Robert Scott, Chairman of the Board, Genpact. 
 
Spek, who also currently serves as Chairman of the Board of Sanofi Germany, spent his career in the pharmaceutical industry where he most recently served as president of Global Operations at Sanofi S.A. before retiring in June 2013. 
 
Beginning his career at Pfizer, where he spent more than 10 years in increasingly responsible product and marketing management roles,Spek then joined Sanofi in 1985. 
 
His tenure there spanned a number of senior management roles including senior vice president of Europe following the merger with Synthélabo in 1999, director of Worldwide Operations of Sanofi-Synthélabo, and executive vice president of Global Pharmaceutical Operations for Sanofi-Aventis before he was promoted to president of Global Operations in 2009. 
 
A native of Germany, he currently resides in Paris.
 
“Genpact is thrilled to add another outstanding business leader to our Board. Hanspeter, who has had such a long and distinguished career in the pharmaceutical and life sciences industry, will bring great insights in one of our core focus industries,” said NV ‘Tiger’ Tyagarajan, president and CEO, Genpact. 
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm